Radiolabeling and efficient synthesis of tritiated 2-chloro-N6-(3-iodobenzyl)adenosine-5′-N-methyluronamide, a potent, selective A3 adenosine receptor agonist

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 38, Issue 6, 1996, Pages 546-560

  Kim, Hea O ^a   Hawes, Calvin ^b   Towers, Pat ^b   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b GENERAL ELECTRIC COMPANY   (United States)

Author keywords

Adenosine Derivatives; Adenosine Receptors; Nucleosides; Radioligands; Tritium

Indexed keywords

BIOMOLECULES; CHLORINE COMPOUNDS;

ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; D RIBOSE; EFFICIENT SYNTHESIS; NUCLEOSIDE; RADIOCHEMICAL PURITY; RADIOLABELLING; RADIOLIGANDS; SPECIFIC ACTIVITY;

TRITIUM;

TRITIUM;

2 CHLORO N6 (3 IODOBENZYL)ADENOSINE 5' N METHYLURON AMIDE; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GASTROINTESTINAL DISEASE; ISOTOPE LABELING; NONHUMAN; RAT; RECEPTOR AFFINITY;

EID: 0029936286     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-1344(199606)38:6<547::aid-jlcr870>3.0.co;2-y     Document Type: Article

References (14)

1. Jacobson M.A. "Molecular biology of adenosine receptors" in Adenosine and adenine nucleotides: From molecular biology to integrative physiology, Kluwer, Boston, 1995, pp. 5-19.
2. (a) Zhou Q.Y., Li C.Y., Olah M.E., Johnson R.A., Stiles G.L., and Civelli O. - Proc. Natl. Acad. Sci. U.S.A. 89: 7432 (1992).
3. (b) Meyerhof, W., Müller-Brechlin, R., Richter, D. FEBS Lett. 284: 155 (1991).
4. Fozard J.R. and Carruthers A.M. - Br. J. Pharmacol. 109: 3 (1993).
5. Ramkurnar V., Stiles G.L., Beaven M.A., and Ali H. - J. Biol. Chem. 268: 16887 (1993).
6. Liu G.S., Richards R.A., Olsson R.A., Mullane K., Walsh R.S., and Downey J.M. - Cardiovasc. Res. 28: 1057 (1994).
7. Kim H.O., Ji X.D., Siddiqi S.M., Olah M.E., Stiles G.L., and Jacobson K.A. - J. Med. Chem. 37: 3614 (1994).
8. Gallo-Rodriguez C., Ji X.D., Melman N., Siegman B.D., Sanders L.H., Orlina J., Fischer B., Pu Q.L., Olah M.E., van Galen P.J.M., Stiles G.L., and Jacobson K.A. - J. Med. Chem. 37: 636 (1994).
9. Jacobson K.A., Kim H.O., Siddiqi S.M., Olah M.E., Stiles G.L., and von Lubitz, D.K.J.E. - Drugs of the Future 20: 689 (1995).
10. (a) Evans E.A., Sheppard H.C., Turner J.C., and Warrell D.C. - J. Labelled Compounds 10: 569 (1974).
11. (b) Jacobson K. A., Ukena D., Padgett W., Kirk K. L., and Daly, J. W. - Biochem. Pharmacol. 36: 1697 (1987).
12. Vorbrüggen H., Krolikiewicz K., and Bennua B. - Chem. Ber. 114: 1234 (1981).
13. Diago-Meseguer J. and Palomo-Coll A.L. - Synthesis 547 (1980).
14. Leonard N.J. and Carraway K.L. - J. Chem. Soc. 485 (1966).